Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

 

Clinical Research on Dyspnea
Author Bios
What is Dyspnea?
What Provokes Dyspnea?
The Nature of Dyspnea
Language of Dyspnea
Clinical Application
Research Application
Variability in Sensations
Challenges in Study
Mechanical Loads and Sense of Effort
Chemoreceptors
Mechanoreceptors
Neuro-Mechanical Dissociation
Phase of Respiration and Dyspnea
Physiology of Dyspnea
Respiratory System
Cardiovascular System
Measuring Dyspnea
Scaling Issues
Qualitative Aspects
Reliability and Validity Overview
Reliability and Validity
Sensitivity and Specificity
Scales
Sensation vs. Perception vs. Symptom
Treating Dyspnea
Why Measure?
Cluster Analysis
Statistical vs. Clinical Significance
Standard Error of Measurement
Measuring Fatigue
Currently selected section: Measuring Depression
Measuring Anxiety and Hyperventilation
Measuring Quality of Life
Conclusion

 

Chapter 23: Dyspnea: Measuring Dyspnea-Related Depression
        

A randomized double-blind study is conducted of the efficacy of steroids in alleviating dyspnea in patients with COPD. Of those patients who report less breathing discomfort with steroids, only a subset have objective evidence of improvement in lung function.

Question 31.1

The likely explanation for the reduction in dyspnea in the remaining patients is:

Selection A Improved lung function not detected by the tests
Selection B Placebo effect
Selection CChange in mood
Selection DImproved cardiac performance


Page 44 of 47
      Previous Section